Keywords: بیماری های نادر; Rare diseases; Birth defects; Surveillance; Health outcomes; Prevention;
مقالات ISI بیماری های نادر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بیماری های نادر; Rare diseases; Hereditary metabolic diseases; Genetic diseases; Mucopolysaccharidosis; Children with special needs; Transition; Enfermedades raras; Enfermedades metabólicas hereditarias; Enfermedades genéticas; Mucopolisacaridosis; Niños con necesidade
Keywords: بیماری های نادر; Enfermedades raras; Enfermedades metabólicas hereditarias; Enfermedades genéticas; Mucopolisacaridosis; Niños con necesidades especiales; Transición; Rare diseases; Hereditary metabolic diseases; Genetic diseases; Mucopolysaccharidosis; Children with
Keywords: بیماری های نادر; Legislation; Policy issues; Rare diseases; Orphan drugs; Europe;
Keywords: بیماری های نادر; botulism; cost-effectiveness; efficacy; human botulism immune globulin; infant botulism; orphan disease; orphan drug; rare diseases; BIG-IV; Human Botulism Immune Globulin Intravenous; CDPH; California Department of Public Health; FDA; US Food and Drug Ad
Keywords: بیماری های نادر; orphan drug production; rare diseases; neglected diseases; orphan diseases; economics; financing;
Keywords: بیماری های نادر; citizens' jury; deliberative methods; health policy; qualitative research; rare diseases; resource allocation;
Keywords: بیماری های نادر; Orphan drugs; Rare diseases; Access; Pricing; Reimbursement; The Balkans;
Keywords: بیماری های نادر; Ultra-orphan drugs; Rare Diseases; Reimbursement status; Patient access;
Keywords: بیماری های نادر; France; Stated preferences; Discrete choice experiment; Latent class analysis; Genetic testing; Whole genome sequencing; Rare diseases;
Keywords: بیماری های نادر; Next-generation sequencing; Legal framework; Translational research; France and quebec; Rare diseases; Cancer;
Keywords: بیماری های نادر; Abdominal pain; Diarrhoea; Enzyme replacement therapy; Fabry disease; Lysosomal storage disorders; OMIM #301500; Rare diseases;
Keywords: بیماری های نادر; Orphan drugs; Rare diseases; Expert consensus; Delphi technique; Spain;
Keywords: بیماری های نادر; Meta-analysis; Zero events; Small populations; Rare diseases; Heterogeneity;
Keywords: بیماری های نادر; costs and cost analysis; economic; economics; medical; models; rare diseases;
Keywords: بیماری های نادر; Ewing sarcoma; EWSR1-FLI1 fusion; Literature review; Rare diseases; Reverse-transcription polymerase chain reaction; Spinal intradural extramedullary tumors; MRI; Magnetic resonance imaging;
Keywords: بیماری های نادر; Software; Computational biology; Method; Data warehouse; Rare diseases; Electronic health records; Information storage and retrieval; Text-mining;
Keywords: بیماری های نادر; Orphan drugs; Rare diseases; Drug pricing; Public policy;
Keywords: بیماری های نادر; Extramammary Paget's disease; Mohs micrographic surgery; vulvar cancer; rare diseases;
Keywords: بیماری های نادر; Rare diseases; Cancer; Health care systems; Cost;
Keywords: بیماری های نادر; Lysosomal storage disorders; Lysosomal disorders; Whole exome sequencing; Inborn errors of metabolism; Undiagnosed diseases; Rare diseases;
Keywords: بیماری های نادر; diagnostic error; rare diseases; medical error; cognitive bias; URD; Undiagnosed and Rare Disease;
Keywords: بیماری های نادر; Case report; Scientific publication; Rare diseases; Evidence-based medicine; Knowledge; Hypothesis; Objectivity; Ethics; Authorship; Caso clÃnico; Publicación cientÃfica; Enfermedades raras; Medicina basada en la evidencia; Conocimiento; Hipótesis; Ob
Keywords: بیماری های نادر; Data warehouse; Vector space model; Similarity measures; Rare diseases; Electronic health records;
Keywords: بیماری های نادر; health technology assessment; orphan drugs; rare diseases; value assessments;
Keywords: بیماری های نادر; Clinical trials; Rare diseases; Bayesian adaptive designs; Sequential allocation; Bandit models; Dynamic programming;
Keywords: بیماری های نادر; Glutathione; S-adenosylmethionine; S-glutathionylation; Epigenetics; Histone; MicroRNAs; DNA methylation; Rare diseases;
Keywords: بیماری های نادر; Acute coronary syndrome; Drug hypersensivity; Miocardial infarction; Coronary vasospasm; Rare diseases;
Keywords: بیماری های نادر; Inborn errors; Neurocognitive; Clinical outcome assessment; Natural history studies; Rare diseases; Drug development;
Keywords: بیماری های نادر; Acute coronary syndrome; Coronary vasospasm; Drug hypersensitivity; Myocardial infarction; Rare diseases; Antibiotics;
Keywords: بیماری های نادر; Encephalopathy; Posterior reversible encephalopathy syndrome; Rare diseases; Subacute diencephalic angioencephalopathy; Vasculopathy
Keywords: بیماری های نادر; Rare diseases; Oncology service; Hospital; Cancer care facilities; Centralized hospital services; Referral and consultation; Maladies rares; Services d'oncologie; Hôpital; Services hospitaliers centralisés; Référencement et consultation;
Keywords: بیماری های نادر; Family-centred care; Prenatal care; Maternity services; Dysmelia; Rare diseases;
Keywords: بیماری های نادر; Seltene Erkrankungen; Versorgungsforschung; Gesundheitspolitik; Nationaler Aktionsplan; Gesundheitssystem; Rare diseases; healthcare research; health policy; national plan of action; healthcare System;
Keywords: بیماری های نادر; Rare diseases; Parents; Children; Supportive care needs; Experiences;
Keywords: بیماری های نادر; L5; H51; I11; I18; Pharmaceutical pricing and reimbursement; Rare diseases; Optimal sample size; Static and dynamic efficiency; Cost-effectiveness threshold;
Keywords: بیماری های نادر; Hiperostosis frontal interna; Enfermedades raras; MeningiomasHyperostosis frontalis interna; Rare diseases; Meningiomas
Keywords: بیماری های نادر; Pulmonary alveolar proteinosis; Rare diseases; Treatment; Granulocyte colony-stimulating factor-macrophageProteinosis alveolar pulmonar; Enfermedades raras; Tratamiento; Factor estimulante de colonias de granulocitos-macrófagos
Keywords: بیماری های نادر; Proteinosis alveolar pulmonar; Enfermedades raras; Tratamiento; Factor estimulante de colonias de granulocitos-macrófagos; Pulmonary alveolar proteinosis; Rare diseases; Treatment; Granulocyte colony-stimulating factor-macrophage;
Keywords: بیماری های نادر; Rare diseases; Policy; Healthcare planning; Codification; Registries; Orphan drugs;
Keywords: بیماری های نادر; Rare diseases; Lipomatosis; Brown adipose tissue; UCP 1; Lipoprotein-lipase; Hyper-alpha-lipoproteinemia
Keywords: بیماری های نادر; Orphan drugs; Rare diseases; Public and patient involvement; Coverage; Decision-making; Policy;
Keywords: بیماری های نادر; Polymer therapeutics; Drug delivery; Polymer-drug conjugate; Polymeric drug; Rare diseases; Amyloid disrupters
Keywords: بیماری های نادر; Cost of illness; Rare diseases; Socioeconomic impact; Systematic review; Orphan drugs; BURQoL-RD;
Keywords: بیماری های نادر; Parents; Supportive care needs; Rare diseases; Impact; Framework;
Keywords: بیماری های نادر; Polymer therapeutics; Drug delivery; Drug design; Nanoconjugates; Polymer-drug conjugate; Rare diseases;
Keywords: بیماری های نادر; Medical care; Developmental delay disorders; Autism; Rare diseases; Paediatric neurologyActividad asistencial; Retraso psicomotor; Autismo; Enfermedades raras; Neuropediatría
Keywords: بیماری های نادر; IEM; inborn errors of metabolism; NIH; National Institutes of Health; ODS; Office of Dietary Supplements; ORDR; Office of Rare Diseases Research; HRSA; Health Resources and Services Administration; PKU; phenylketonuria; PAH; phenylalanine hydroxylase; PHE
Keywords: بیماری های نادر; Liver transplantation; Surgical gene therapy; Genetic diseases; Inborn; Metabolic diseases; Rare diseases;
Keywords: بیماری های نادر; Rare diseases; Biomedical databases; Disease relations; Protein interactions